• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study

tetano

Editor, Senior Moderator
Intensive Care Med. 2016 Feb 15. [Epub ahead of print]
[h=1]The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.[/h] Sakr Y[SUP]1[/SUP], Ferrer R[SUP]2[/SUP], Reinhart K[SUP]3[/SUP], Beale R[SUP]4[/SUP], Rhodes A[SUP]5[/SUP], Moreno R[SUP]6[/SUP], Timsit JF[SUP]7[/SUP], Brochard L[SUP]8,[/SUP][SUP]9[/SUP], Thompson BT[SUP]10,[/SUP][SUP]11[/SUP], Rezende E[SUP]12[/SUP], Chiche JD[SUP]13,[/SUP][SUP]14,[/SUP][SUP]15[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]PURPOSE:[/h] In this prospective, multicenter, 14-day inception cohort study, we investigated the epidemiology, patterns of infections, and outcome in patients admitted to the intensive care unit (ICU) as a result of severe acute respiratory infections (SARIs).
[h=4]METHODS:[/h] All patients admitted to one of 206 participating ICUs during two study weeks, one in November 2013 and the other in January 2014, were screened. SARI was defined as possible, probable, or microbiologically confirmed respiratory tract infection with recent onset dyspnea and/or fever. The primary outcome parameter was in-hospital mortality within 60 days of admission to the ICU.
[h=4]RESULTS:[/h] Among the 5550 patients admitted during the study periods, 663 (11.9 %) had SARI. On admission to the ICU, Gram-positive and Gram-negative bacteria were found in 29.6 and 26.2 % of SARI patients but rarely atypical bacteria (1.0 %); viruses were present in 7.7 % of patients. Organ failure occurred in 74.7 % of patients in the ICU, mostly respiratory (53.8 %), cardiovascular (44.5 %), and renal (44.6 %). ICU and in-hospital mortality rates in patients with SARI were 20.2 and 27.2 %, respectively. In multivariable analysis, older age, greater severity scores at ICU admission, and hematologic malignancy or liver disease were independently associated with an increased risk of in-hospital death, whereas influenza vaccination prior to ICU admission and adequate antibiotic administration on ICU admission were associated with a lower risk.
[h=4]CONCLUSIONS:[/h] Admission to the ICU for SARI is common and associated with high morbidity and mortality rates. We identified several risk factors for in-hospital death that may be useful for risk stratification in these patients.


[h=4]KEYWORDS:[/h] Intensive care; Outcome; Pneumonia; Severe acute respiratory infections

PMID: 26880091 [PubMed - as supplied by publisher]
 
Back
Top Bottom